FDA approves Synergy's constipation drug

FDA approved once-daily oral Trulance plecanatide from Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) to treat chronic idiopathic constipation (CIC)

Read the full 175 word article

User Sign In